Effects of zinc, magnesium, and chromium supplementation on cardiometabolic risk in adults with metabolic syndrome: A double-blind, placebo-controlled randomised trial.
Published Jul 1, 2018 · Ha-Na Kim, Se-Hong Kim, Youngmi Eun
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements
19
Citations
0
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayZinc, magnesium, and chromium supplementation did not significantly change metabolic risk factors in adults with metabolic syndrome, but decreased serum C-reactive protein levels.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.